Literature DB >> 15514988

Differential expression of T-type calcium channels in P/Q-type calcium channel mutant mice with ataxia and absence epilepsy.

Sang-Soep Nahm1, Ki-Yoon Jung, Melanie Krause Enger, William H Griffith, Louise C Abbott.   

Abstract

Mutations in P/Q-type calcium channels generate common phenotypes in mice and humans, which are characterized by ataxia, paroxysmal dyskinesia, and absence seizures. Subsequent functional changes of T-type calcium channels in thalamus are observed in P/Q-type calcium channel mutant mice and these changes play important roles in generation of absence seizures. However, the changes in T-type calcium channel function and/or expression in the cerebellum, which may be related to movement disorders, are still unknown. The leaner mouse exhibits severe ataxia, paroxysmal dyskinesia, and absence epilepsy due to a P/Q-type calcium channel mutation. We investigated changes in T-type calcium channel expression in the leaner mouse thalamus and cerebellum using quantitative real-time polymerase chain reaction (qRT-PCR) and quantitative in situ hybridization histochemistry (ISHH). qRT-PCR analysis showed no change in T-type calcium channel alpha 1G subunit (Cav3.1) expression in the leaner thalamus, but a significant decrease in alpha 1G expression in the whole leaner mouse cerebellum. Interestingly, quantitative ISHH revealed differential changes in alpha 1G expression in the leaner cerebellum, where the granule cell layer showed decreased alpha 1G expression while Purkinje cells showed increased alpha 1G expression. To confirm these observations, the granule cell layer and the Purkinje cell layer were laser capture microdissected separately, then analyzed with qRT-PCR. Similar to the observation obtained by ISHH, the leaner granule cell layer showed decreased alpha 1G expression and the leaner Purkinje cell layer showed increased alpha 1G expression. These results suggest that differential expression of T-type calcium channels in the leaner cerebellum may be involved in the observed movement disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15514988     DOI: 10.1002/neu.20107

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  6 in total

1.  Molecular identity and functional properties of a novel T-type Ca2+ channel cloned from the sensory epithelia of the mouse inner ear.

Authors:  Liping Nie; Jun Zhu; Michael Anne Gratton; Amy Liao; Karen J Mu; Wolfgang Nonner; Guy P Richardson; Ebenezer N Yamoah
Journal:  J Neurophysiol       Date:  2008-08-27       Impact factor: 2.714

2.  Normal motor learning during pharmacological prevention of Purkinje cell long-term depression.

Authors:  John P Welsh; Hidetoshi Yamaguchi; Xiao-Hui Zeng; Masanobu Kojo; Yasushi Nakada; Akiko Takagi; Mutsuyuki Sugimori; Rodolfo R Llinás
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-08       Impact factor: 11.205

3.  Effects of familial hemiplegic migraine type 1 mutation T666M on voltage-gated calcium channel activities in trigeminal ganglion neurons.

Authors:  Jin Tao; Ping Liu; Zheman Xiao; Hucheng Zhao; Benjamin R Gerber; Yu-Qing Cao
Journal:  J Neurophysiol       Date:  2011-12-21       Impact factor: 2.714

4.  Genetic enhancement of thalamocortical network activity by elevating alpha 1g-mediated low-voltage-activated calcium current induces pure absence epilepsy.

Authors:  Wayne L Ernst; Yi Zhang; Jong W Yoo; Sara J Ernst; Jeffrey L Noebels
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

5.  Alterations in intracellular calcium ion concentrations in cerebellar granule cells of the CACNA1A mutant mouse, leaner, during postnatal development.

Authors:  Bhupinder Bawa; Louise C Abbott
Journal:  Neurotox Res       Date:  2009-12-31       Impact factor: 3.911

6.  Review: Cav2.3 R-type Voltage-Gated Ca2+ Channels - Functional Implications in Convulsive and Non-convulsive Seizure Activity.

Authors:  Carola Wormuth; Andreas Lundt; Christina Henseler; Ralf Müller; Karl Broich; Anna Papazoglou; Marco Weiergräber
Journal:  Open Neurol J       Date:  2016-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.